Quest report: Marijuana showing up more frequently in post-accident testing
A report for 2022 from Quest Diagnostics indicates the presence of marijuana in tests after accidents was at its highest figure in...
ChristianaCare spin-out named ‘Most Promising New Company’ at Delaware Bio pitch event
CorriXR Therapeutics was voted “Most Promising New Company” by attendees last week at the first-ever Delaware BioScience Association (Delaware Bio) conference.
The first spin-out of...
My take: Covid-19 hangs around
At 6 p.m. last night, Gov. John Carney lifted the Covid-19 Public Health Emergency for Covid-19.
The Biden Administration made a similar decision...
AstraZeneca’s Farxiga approved for treating wider range of heart failure patients
AstraZeneca’s blockbuster drug Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular death, hospitalization for heart failure (HF), and urgent...
ChristianaCare opens Sleep Wellness Center
(ChristianaCare photo of Dr. Shilpa Kauta)
ChristianaCare opened its Comprehensive Sleep Wellness Center on the Newark Campus.
The center is staffed by board-certified sleep...
Billing company to provide services for radiology practice in Sussex County
Healthcare Administrative Partners (HAP), an outsourced billing, coding, and practice management solutions for radiology practices, announced the addition of Southern Delaware Imaging Associates...
‘Head shops’ no longer in legal gray area as next phase of weed legalization...
(From the Delaware Cannabis Advocacy Network)
At midnight tonight, Delaware will join 21 other states and three U.S. territories by passing a law to legalize...
Trial shows AstraZeneca-Ionis drug shown to be effective in treating rare nerve disease
Detailed results from a Phase III trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy showed AstraZeneca and Ionis’ eplontersen showed positive results.
The ...
New Castle County, state agency to analyze wastewater for presence of illegal drugs
New Castle County announced a new partnership with Delaware’s Department of Health and Social Services and Division of Substance Abuse and Mental Health ...
Reactions to marijuana becoming legal in Delaware
It is no longer illegal to possess small quantities of marijuana in Delaware. Gov. John Carney opted not to sign or veto bills that...
Gov. Carney will allow 2 marijuana legalization bills to become law
Delaware Gov. John Carney on Friday will allow two bills that pave the way for legalized recreational marijuana to become law without his...
Columbia Care rolls out new baked goods edibles on 4/20
Columbia Care rolls out new baked goods edibles on 4/20
On the unofficial 4/20 holiday, marijuana giant Columbia Care announced a collaboration with the...
Clock ticking on weed legalization bills
The clock is ticking on two measures that would legalize and regulate recreational marijuana for adult users were delivered to Gov. John Carney this week.
Collectively, Rep. Ed...
Governor to end Covid emergency order on May 11
Governor John Carney on Thursday announced plans to end the State of Delaware’s Public Health Emergency order at the end of the day...
Delaware Health Information Network announces security certification
The Delaware Health Information Network announced the following technology and services have earned certified status by HITRUST for information securit - Analytics SFTP Server;...
Former Connections CEO agrees to pay $300,000 to settle federal lawsuit
Catherine Devaney McKay, the former CEO of Connections Community Support Programs, Inc. (“CCSP”), has agreed to pay $300,000 to resolve alleged violations of the...
ChristianaCare plans to operate ‘micro hospital’ at Jennersville site in 2024
ChristianaCare confirmed Tuesday that it will operate a small hospital at its West Grove Campus, formerly Jennersville Hospital.
ChristianaCare will open a neighborhood "micro...
Sierra Club to hold webinar early Monday night on proposed 2035 electric vehicle mandate
(Photo of Kempton)
The Sierra Club of Delaware will hold a conversation via webinar to discuss Delaware’s consideration of adoption of the Advanced Clean Cars II...
Incyte gets accelerated approval for skin cancer drug
The U.S. Food and Drug Administration (FDA) has received accelerated approval for Zynyz (retifanlimab-dlwr), afor the treatment of adults with a rare form ...
Incyte reports positive results in 2-year trial of drug used to treat loss of...
Incyte announced positive two-year results from the pivotal Phase 3 TRuE-V clinical trial program evaluating Opzelura (ruxolitinib) cream 1.5% in patients 12 years of...
